EA201590125A1 - ПИПЕРАЗИНО[1,2-a]ИНДОЛ-1-ОНЫ И [1,4]ДИАЗЕПИНО[1,2-a]ИНОДОЛ-1-ОН - Google Patents
ПИПЕРАЗИНО[1,2-a]ИНДОЛ-1-ОНЫ И [1,4]ДИАЗЕПИНО[1,2-a]ИНОДОЛ-1-ОНInfo
- Publication number
- EA201590125A1 EA201590125A1 EA201590125A EA201590125A EA201590125A1 EA 201590125 A1 EA201590125 A1 EA 201590125A1 EA 201590125 A EA201590125 A EA 201590125A EA 201590125 A EA201590125 A EA 201590125A EA 201590125 A1 EA201590125 A1 EA 201590125A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lower alkyl
- halogen
- substituted
- disease
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
Abstract
Изобретение относится к соединениям общей формулы Iгде Rпредставляет собой водород, галоген, низший алкил, низший алкокси, низший алкокси, замещенный галогеном или циано; Rпредставляет собой водород, низший алкил или низший алкил, замещенный галогеном; Rпредставляет собой фенил, бензо[1,3]диоксолил, 2,3-дигидробензофуран-5-ил или 5- и 6-членный гетероарил, где фенил и 5- и 6-членные гетероарильные группы могут быть замещены одним или более заместителями, выбранными из циано, нитро, амино и низшего диалкиламино, низшего алкилсульфонила, низшего алкокси, низшего алкокси, замещенного галогеном, галогена, низшего алкила, низшего алкила, замещенного галогеном, или низшего алкила, замещенного гидроксилом; X представляет собой -СН(низший алкил)-, -СН-, -СНСН- или -СН(низший алкил)СН-; R представляет собой водород или низший алкил; n представляет собой 1 или 2; или к фармацевтически приемлемым кислотно-аддитивным солям, рацемическим смесям или их соответствующим энантиомерам и/или их оптическим изомерам. Соединения могут применяться для лечения шизофрении, обсессивно-компульсивного расстройства личности, большой депрессии, биполярных расстройств, тревожных расстройств, обычного старения, эпилепсии, дегенерации сетчатки, черепно-мозговой травмы, повреждения спинного мозга, посттравматического стресса, панического расстройства, болезни Паркинсона, деменции, болезни Альцгеймера, умеренных когнитивных нарушений, вызванной химиотерапией когнитивной дисфункции ("химический мозг"), синдрома Дауна, заболеваний аутистического спектра, потери слуха, шума в ушах, спиноцеребеллярной атаксии, латерального амиотрофического склероза, рассеянного склероза, болезни
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12179381 | 2012-08-06 | ||
PCT/EP2013/066344 WO2014023674A1 (en) | 2012-08-06 | 2013-08-05 | Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201590125A1 true EA201590125A1 (ru) | 2015-05-29 |
EA025884B1 EA025884B1 (ru) | 2017-02-28 |
Family
ID=48918402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201590125A EA025884B1 (ru) | 2012-08-06 | 2013-08-05 | ПИПЕРАЗИНО[1,2-a]ИНДОЛ-1-ОНЫ И [1,4]ДИАЗЕПИНО[1,2-a]ИНДОЛ-1-ОН |
Country Status (25)
Country | Link |
---|---|
US (1) | US9284321B2 (ru) |
EP (1) | EP2880036B1 (ru) |
JP (1) | JP5974177B2 (ru) |
KR (1) | KR101716062B1 (ru) |
CN (1) | CN104540829B (ru) |
AR (1) | AR092041A1 (ru) |
AU (1) | AU2013301577B2 (ru) |
BR (1) | BR112015000313A2 (ru) |
CA (1) | CA2880682A1 (ru) |
CL (1) | CL2015000143A1 (ru) |
CO (1) | CO7141435A2 (ru) |
CR (1) | CR20140545A (ru) |
EA (1) | EA025884B1 (ru) |
HK (1) | HK1206355A1 (ru) |
IL (1) | IL236808B (ru) |
MA (1) | MA37791B1 (ru) |
MX (1) | MX362184B (ru) |
MY (1) | MY185216A (ru) |
NZ (1) | NZ703192A (ru) |
PE (1) | PE20150341A1 (ru) |
PH (1) | PH12015500059B1 (ru) |
SG (1) | SG11201408529VA (ru) |
TW (1) | TWI506027B (ru) |
UA (1) | UA113013C2 (ru) |
WO (1) | WO2014023674A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201506420WA (en) * | 2013-02-18 | 2015-09-29 | Theranos Inc | Image analysis and measurement of biological samples |
KR101767329B1 (ko) * | 2013-04-02 | 2017-08-10 | 에프. 호프만-라 로슈 아게 | 피페라지노[1,2-a]인돌-1-온 및 [1,4]다이아제피노[1,2-a]인돌-1-온 |
CA2917628A1 (en) * | 2013-09-12 | 2015-03-19 | F. Hoffmann-La Roche Ag | Indol-carboxamide derivatives |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1965981C3 (de) * | 1968-02-13 | 1978-08-31 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | 9-Phenyl-lO-oxopiperazino [l,2-a]-indole und Verfahren zu ihrer Herstellung |
GB0106177D0 (en) * | 2001-03-13 | 2001-05-02 | Hoffmann La Roche | Piperazine derivatives |
GB0202015D0 (en) * | 2002-01-29 | 2002-03-13 | Hoffmann La Roche | Piperazine Derivatives |
AU2006324089A1 (en) * | 2005-12-09 | 2007-06-14 | F. Hoffmann-La Roche Ag | Tricyclic amide derivatives useful for treating obesity |
WO2008046072A2 (en) | 2006-10-13 | 2008-04-17 | The Board Of Regents Of The University Of Texas System | Chemical inducers of neurogenesis |
MX2009004898A (es) * | 2006-11-09 | 2009-05-19 | Hoffmann La Roche | Derivados de indol y de benzofurano-2-carboxamida. |
BR112013000414A2 (pt) | 2010-07-07 | 2016-05-17 | Univ Texas | compostos proneurogênicos |
KR101767329B1 (ko) * | 2013-04-02 | 2017-08-10 | 에프. 호프만-라 로슈 아게 | 피페라지노[1,2-a]인돌-1-온 및 [1,4]다이아제피노[1,2-a]인돌-1-온 |
-
2013
- 2013-08-05 TW TW102128001A patent/TWI506027B/zh not_active IP Right Cessation
- 2013-08-05 BR BR112015000313A patent/BR112015000313A2/pt not_active Application Discontinuation
- 2013-08-05 PE PE2015000024A patent/PE20150341A1/es active IP Right Grant
- 2013-08-05 MX MX2015001318A patent/MX362184B/es active IP Right Grant
- 2013-08-05 SG SG11201408529VA patent/SG11201408529VA/en unknown
- 2013-08-05 KR KR1020157003112A patent/KR101716062B1/ko active IP Right Grant
- 2013-08-05 CN CN201380041546.5A patent/CN104540829B/zh active Active
- 2013-08-05 CA CA2880682A patent/CA2880682A1/en not_active Abandoned
- 2013-08-05 EP EP13745648.9A patent/EP2880036B1/en active Active
- 2013-08-05 NZ NZ703192A patent/NZ703192A/en not_active IP Right Cessation
- 2013-08-05 EA EA201590125A patent/EA025884B1/ru not_active IP Right Cessation
- 2013-08-05 AU AU2013301577A patent/AU2013301577B2/en not_active Ceased
- 2013-08-05 AR ARP130102771A patent/AR092041A1/es unknown
- 2013-08-05 MY MYPI2014003519A patent/MY185216A/en unknown
- 2013-08-05 UA UAA201501071A patent/UA113013C2/uk unknown
- 2013-08-05 WO PCT/EP2013/066344 patent/WO2014023674A1/en active Application Filing
- 2013-08-05 JP JP2015525846A patent/JP5974177B2/ja active Active
-
2014
- 2014-11-27 CR CR20140545A patent/CR20140545A/es unknown
- 2014-11-28 CO CO14262433A patent/CO7141435A2/es unknown
-
2015
- 2015-01-09 PH PH12015500059A patent/PH12015500059B1/en unknown
- 2015-01-19 IL IL236808A patent/IL236808B/en not_active IP Right Cessation
- 2015-01-20 MA MA37791A patent/MA37791B1/fr unknown
- 2015-01-21 CL CL2015000143A patent/CL2015000143A1/es unknown
- 2015-02-04 US US14/614,232 patent/US9284321B2/en active Active
- 2015-07-24 HK HK15107077.4A patent/HK1206355A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016502231B1 (en) | Indolin-2-one or pyrrolo-pyridin-2-one derivatives | |
MX2016008842A (es) | Derivados de n-fenil-lactama capaces de estimular la neurogenesis y su uso en el tratamiento de trastornos neurologicos. | |
MX366855B (es) | Compuestos perfluorados de 5,6-dihidro-4h-1,3-oxazin-2-amina como inhibidores de beta-secretasa y metodos de uso. | |
EA201390971A1 (ru) | ИМИДАЗО[5,1-f][1,2,4]ТРИАЗИНЫ ДЛЯ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ | |
EP3572417A3 (en) | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof | |
AR096640A1 (es) | Derivados de indolin-2-ona o pirrolo-piridin / pirimidin-2-ona | |
BR112015004942A2 (pt) | benzimidazóis como agentes ativos do snc | |
MX2016000895A (es) | Derivados de 1,7-naftiridina. | |
EA201491116A1 (ru) | Производные 6-дифторметил-5,6-дигидро-2h-[1,4]оксазин-3-амина | |
AR093576A1 (es) | Derivados heterociclicos sustituidos | |
EA201590438A1 (ru) | 2-оксо-2,3-дигидроиндолы для лечения расстройств центральной нервной системы | |
MX2015015052A (es) | Derivados de isoquinolina que estimulan la neurogenesis. | |
AR106588A1 (es) | Derivados de indolin-2-ona para el tratamiento de enfermedades del snc | |
MX2015006364A (es) | 1,6-naftiridinas sustituidas. | |
EA201590125A1 (ru) | ПИПЕРАЗИНО[1,2-a]ИНДОЛ-1-ОНЫ И [1,4]ДИАЗЕПИНО[1,2-a]ИНОДОЛ-1-ОН | |
EA201690971A1 (ru) | ПИРИДО[4,3-b]ПИРАЗИН-2-КАРБОКСАМИДЫ В КАЧЕСТВЕ НЕЙРОГЕННЫХ СРЕДСТВ ДЛЯ ЛЕЧЕНИЯ НЕЙРОДЕГЕНЕРАТИВНЫХ РАССТРОЙСТВ | |
BR112015008200A2 (pt) | derivados de imidazopiridina | |
BR112016024149A2 (pt) | derivados de indolin-2-ona e 1,3-di-hidro-pirrol[3,2-c]piridin-2-ona | |
MX2015013915A (es) | Piperazino[1,2-a]indol-1-onas y [1,4]diazepino[1,2-a]indol-1-ona. | |
EA201590014A1 (ru) | Азетидиновые и пиперидиновые соединения, подходящие для применения в качестве ингибиторов pde10 | |
MX2015000629A (es) | Moduladores de benzisoxasol de neurogenesis. | |
MX2016001528A (es) | Derivados de indol-carboxamida. | |
TH165816B (th) | ไพริโด[4,3-b]ไพราซีน-2-คาร์บอกซาไมด์ ในรูปสารก่อกำเนิดประสาทสำหรับ การรักษาความผิดปกติที่มีภาวะเสื่อมของระบบประสาท | |
TH165816A (th) | ไพริโด[4,3-b]ไพราซีน-2-คาร์บอกซาไมด์ ในรูปสารก่อกำเนิดประสาทสำหรับ การรักษาความผิดปกติที่มีภาวะเสื่อมของระบบประสาท |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |